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Background: Health registries may yield important data for epidemiological studies. 
However,	in	order	to	be	a	valuable	source	for	information,	the	registered	data	have	
to be correct.
Objectives: The aim of the study was to validate data from the Norwegian Patient 
Registry (NPR) regarding multiple sclerosis (MS).
Materials and Methods: We obtained data on individuals residing in Nordland County 
and registered with a MS diagnosis in the NPR or in local hospital records. The NPR 
data included a unique 11‐digit personal identity number that made it possible to 




incorrectly. Incorrect registration was due to a diagnosis that did not fulfill the diag‐
nostic	criteria,	later	investigation	had	ruled	out	MS	or	it	was	an	error	in	the	diagnostic	
code registration process. Twenty individuals were not registered with MS in the 
NPR. These were patients who received their diagnosis before data in the NPR were 
person	identifiable	(before	2008),	and	who	later	had	no	MS‐registered	contact	with	
public	specialist	healthcare	services.	The	sensitivity	is	0.97,	and	the	positive	predic‐
tive value is 0.92.
Conclusion: Data	from	the	NPR	gave	a	good	estimate	of	the	occurrence	of	MS,	but	
nearly one in 10 registered diagnoses was not correct.
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1  | INTRODUC TION
Knowledge of the epidemiology of diseases can give clues to under‐
standing the etiology and risk factors of diseases. It is also important 
in healthcare planning.






liability of the collected data.
One of these registries is the Norwegian Patient Registry 
(NPR). NPR is a nationwide Norwegian health registry run by The 
Norwegian Directorate of Health. The registry was established 
in	 1997,	 and	 the	 information	 is	 person	 identifiable	 from	 2008.	
Whenever a patient is treated at a hospital or a private practice 
specialists	with	public	reimbursement,	the	given	diagnoses	with	the	
corresponding International Statistical Classification of Diseases 
and Related Health Problems 10th Revision (ICD‐10) codes are 
mandatorily	reported	to	the	NPR.	By	application,	researchers	may	
get access to data from the registry.
Furthermore,	all	Norwegian	citizens	have	a	unique	11‐digit	per‐
sonal	 identity	 number,	 an	 identity	 designation	 retained	 the	whole	
life. This number is included in every hospital record and is linked to 
a unique number in the NPR.
With	access	 to	detailed	hospital	 records,	we	aimed	 to	validate	




in	Nordland	County	was	 242,866	 (123,108	men,	 119,758	women)	
January	1,	2017.
Nordland County is in the northern part of Norway and includes 
the	regions	of	Helgeland,	Salten,	Ofoten,	and	the	islands	of	Lofoten	
and Vesterålen. The public health services for diagnosing and 
treating MS include the Department of Neurology at the Nordland 
Hospital	 in	 Bodø,	 and	 the	 neurological	 outpatient	 services	 at	 the	
hospitals	 in	 Mosjøen	 (Helgeland)	 and	 Stokmarknes	 (Vesterålen).	
Neurological patients living in the very north of the county (Ofoten) 
are	mostly	served	by	the	hospital	in	Tromsø	(Troms	County),	and	pa‐
tients in the south of the county may be referred to the hospitals in 
the neighboring county to the south.
2.2 | Diagnostic criteria
The diagnosis of MS was based on the criteria of Poser (Poser et 
al,	1983)	or	McDonald	(McDonald	et	al.,	2001;	Polman	et	al.,	2011).	
Individuals were included in the present study if they fulfilled at least 
one of these criteria.
2.3 | Case ascertainment





data from the neurological outpatient clinics in Stokmarknes and 
Mosjøen,	Nordland	County,	and	from	the	hospitals	in	the	neighbor‐
ing	 counties,	Tromsø	 to	 the	north,	 and	Namsos	and	Trondheim	 to	
the south.
From	the	NPR,	we	received	extracted	data	for	all	individuals	with	
a diagnosis of G35 (ICD 10) from Nordland County and for all pa‐
tients with G35 who had had address in Nordland recorded in the 
period	from	January	1,	2008,	to	January	1,	2017.
We	validated	 the	MS	diagnosis	by	 scrutinizing	 the	hospital	 re‐
cords,	of	which	two	of	the	authors	(EB,	KBA)	had	full	access.
2.4 | Statistics
The true number of individuals with MS was determined by count‐
ing and ascertain all subjects identified in the hospital records who 
fulfilled	the	criteria	for	MS	in	Nordland	County	per	January	1,	2017.	
A	true	positive	(TP)	was	an	individual	with	an	MS	diagnosis	registered	




out MS and not registered with MS in the NPR (Table 1). We calcu‐
lated	 the	 sensitivity	 (TP/(TP	+	FN)),	 specificity	 (TN/(TN	+	FP)),	 the	
positive predictive value (TP/(TP + FP)) and the negative predictive 
value	(TN/(TN	+	FN)).	Cohen's	kappa,	where	the	value	0	is	agreement	
equivalent	to	chance	and	1	is	a	perfect	agreement,	was	calculated	to	
compare the data from the NPR with the true number of individuals 
with MS. Statistical analyses were performed by the use of Microsoft 
Excel	for	Windows	7	and	IBM	SPSS	Statistics	version	25.
TA B L E  1  Cross‐table	indicating	the	true‐positive,	false‐positive,	
false‐negative and true‐negative values of individuals with or 
without multiple sclerosis (MS) registered or not registered in the 
Norwegian Patient Registry (NPR)
 
Confirmed MS according to hospital 
records
SUMYes No
Registered MS in the NPR
Yes True positive False positive Total regis‐
tered in NPR
No False negative True negative Total not 
registered in 
NPR
SUM Total with MS Total without MS Total 
population
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2.5 | Ethical approval













1,	 2017,	was	 thus	657,	 giving	 a	 prevalence	of	 270.5	 per	 100,000.	
Twenty of the individuals with MS identified in medical files were 
not	 included	 in	 the	NPR,	and	19	of	 those	were	mildly	affected	by	
the	disease	at	the	latest	consultation	prior	to	2008.	In	23	of	the	59	
individuals registered in the NPR who did not fulfill the diagnostic 
criteria	for	MS	(Figure	1),	later	diagnostic	work‐up	had	ruled	out	MS.	
In	 17	 individuals,	 symptoms	or	 findings	were	 still	 suspect	 for	MS,	





The Cohen's kappa was 0.94.
4  | DISCUSSION
In	Nordland	County,	91.5%	of	those	registered	with	MS	in	the	NPR	
have a confirmed diagnosis of the disease.
Previous analyses of NPR data for correctness and completeness 
in	stroke	in	Norway	have	shown	a	sensitivity	of	96.8%	and	a	spec‐
ificity	of	99.6%,	with	a	positive	predictive	value	of	79.7%	(Varmdal	
et	 al.,	 2016).	 Another	 study,	 focusing	 on	 intracranial	 hemorrhage	
(ICH)	in	Trøndelag,	8.8%	registered	with	ICH	in	the	NPR	showed	to	
be	 false	 positive	 (Øie	 et	 al.,	 2018).	 In	 a	 study	 of	 amyotrophic	 lat‐
eral	sclerosis	(ALS),	data	from	the	NPR	was	validated	for	Akershus—
Hordaland	County,	showing	that	11%	of	individuals	with	at	least	one	
ALS‐related	entry	 in	 the	NPR	had	an	 incorrect	diagnosis	 (Nakken,	
Lindstrøm,	Tysnes,	&	Holmøy,	2018).	These	results	are	in	accordance	




giving a near‐perfect fit.
We	found	that	3.0%	of	those	who	actually	have	MS	are	not	regis‐





to the increasing probability that those who were diagnosed with 
benign	 disease	 prior	 to	 2008	 eventually	 will	 have	 their	 diagnosis	
registered.
Data from the NPR have previously been used in a nationwide 
prevalence	 study	 of	MS	 in	 Norway,	 finding	 a	 national	 prevalence	
of	203	per	100,000	in	2010	(Berg‐Hansen,	Moen,	Harbo,	&	Celius,	
2014).	In	that	study,	unless	they	used	MS	specific	treatment	accord‐
ing	 to	 the	Norwegian	Prescription	Database,	only	 individuals	with	





in	the	NPR	 is	 reduced	from	8.5%	to	3.3%.	On	the	other	hand,	 the	
proportion	of	those	with	MS	that	are	not	included	increases	to	6.4%.
4.1 | Study strengths and limitations
The strength of our study is that the data from the NPR is person‐
ally identifiable and that we were able to validate the diagnosis at an 
individual level. We have a complete overview of the MS population 
in our county and full access to the hospital records. The limitation 
with	 regards	 to	generalizability	 is	 that	we	have	validated	 the	NPR	
F I G U R E  1   Number of individuals with or without multiple 
sclerosis (MS) registered or not registered in the Norwegian Patient 
Registry (NPR)
Number of individuals with MS according to hospital 
records, but are not registered in the NPR, n=20
Number of individuals registered with MS in the NPR, 
but do not have MS according to hospital records, n= 59
Number of individuals registered in the NPR and 
have MS according to hospital records, n=637
TA B L E  2   Cross‐table of individuals with or without multiple 
sclerosis (MS) registered or not registered in the Norwegian Patient 
Registry (NPR)
 
Confirmed MS according to hospital 
records
SUMYes No
Registered MS in the NPR
Yes 637 59 696
No 20 242,150 242,170
SUM 657 242,209 242,866
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with	 regards	 to	MS	 in	only	one	county,	 including	<5%	of	 the	 total	
Norwegian population.
5  | CONCLUSION
Data from the NPR give a good estimate of the real prevalence of MS 
in	Nordland	County,	but	nearly	one	in	10	with	a	registered	diagnosis	
does not fulfill the diagnostic criteria. Data from the NPR should be 
combined with data from other sources if more accurate numbers 
are needed.
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